113 related articles for article (PubMed ID: 27696769)
1. Synthesis and preliminary evaluation of a
Wu X; You L; Zhang D; Gao M; Li Z; Xu D; Zhang P; Huang L; Zhuang R; Wu H; Zhang X
Chem Biol Drug Des; 2017 Apr; 89(4):559-565. PubMed ID: 27696769
[TBL] [Abstract][Full Text] [Related]
2.
Gao F; Peng C; Zhuang R; Guo Z; Liu H; Huang L; Li H; Xu D; Wen X; Fang J; Zhang X
Nucl Med Biol; 2019; 72-73():62-69. PubMed ID: 31330414
[TBL] [Abstract][Full Text] [Related]
3.
Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 7α-(3-[(18)F]fluoropropyl) estradiol.
Okamoto M; Naka K; Kitagawa Y; Ishiwata K; Yoshimoto M; Shimizu I; Toyohara J
Nucl Med Biol; 2015 Jul; 42(7):590-7. PubMed ID: 25823392
[TBL] [Abstract][Full Text] [Related]
5. Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.
Lee JH; Zhou HB; Dence CS; Carlson KE; Welch MJ; Katzenellenbogen JA
Bioconjug Chem; 2010 Jun; 21(6):1096-104. PubMed ID: 20496889
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pre-clinical evaluation of a new class of high-affinity
Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
[TBL] [Abstract][Full Text] [Related]
7. Radiosynthesis, biological evaluation and preliminary microPET study of
Kang J; Young Lee J; Taş İ; More KN; Kim H; Park JH; Chang DJ
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3658-3664. PubMed ID: 30528977
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
11. Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targeting.
Betzel T; Müller C; Groehn V; Müller A; Reber J; Fischer CR; Krämer SD; Schibli R; Ametamey SM
Bioconjug Chem; 2013 Feb; 24(2):205-14. PubMed ID: 23273015
[TBL] [Abstract][Full Text] [Related]
12. (18)F-trifluoroborate derivatives of [des-arg(10)]kallidin for imaging bradykinin b1 receptor expression with positron emission tomography.
Liu Z; Amouroux G; Zhang Z; Pan J; Hundal-Jabal N; Colpo N; Lau J; Perrin DM; Bénard F; Lin KS
Mol Pharm; 2015 Mar; 12(3):974-82. PubMed ID: 25629412
[TBL] [Abstract][Full Text] [Related]
13. 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.
Wu Z; Li ZB; Cai W; He L; Chin FT; Li F; Chen X
Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1823-1831. PubMed ID: 17492285
[TBL] [Abstract][Full Text] [Related]
14. Radioiodinated estradiol dimer for estrogen receptor targeted breast cancer imaging.
Xu D; Peng C; Gao F; Guo Z; Zhuang R; Su X; Zhang X
Chem Biol Drug Des; 2020 Dec; 96(6):1332-1340. PubMed ID: 32603003
[TBL] [Abstract][Full Text] [Related]
15. Design and Investigation of a [
Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME
Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker.
Zhu C; Xu Q; Pan D; Xu Y; Liu P; Yang R; Wang L; Sun X; Luo S; Yang M
Contrast Media Mol Imaging; 2016; 11(2):99-105. PubMed ID: 26286841
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake.
Zhang Z; Amouroux G; Pan J; Jenni S; Zeisler J; Zhang C; Liu Z; Perrin DM; Bénard F; Lin KS
Mol Pharm; 2016 Aug; 13(8):2823-32. PubMed ID: 27348517
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 2-(3,4-dimethoxyphenyl)-6-(2-[
Li GY; Vaulina DD; Li JJ; Fedorova OS; Wang HE; Liu RS; Krasikova RN; Chen CL
Bioorg Med Chem Lett; 2017 Aug; 27(15):3460-3463. PubMed ID: 28619538
[TBL] [Abstract][Full Text] [Related]
19. Side Chain Optimization Remarkably Enhances the in Vivo Stability of
Chen J; Li C; Hong H; Liu H; Wang C; Xu M; Han Y; Liu Z
Mol Pharm; 2019 Dec; 16(12):5035-5041. PubMed ID: 31670970
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeled R954 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography.
Kuo HT; Pan J; Lau J; Zhang C; Zeisler J; Colpo N; Bénard F; Lin KS
Mol Pharm; 2017 Mar; 14(3):821-829. PubMed ID: 28094956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]